| Page 34 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.
  1. Home

Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

Author(s): 
Sauta E, Robin M, Bersanelli M, Travaglino E, Meggendorfer M, Zhao LP, Caballero Berrocal JC, Sala C, Maggioni G, Bernardi M, Di Grazia C, Vago L, Rivoli G, Borin L, D'Amico S, Tentori CA, Ubezio M, Campagna A, Russo A, Mannina D, Lanino L, Chiusolo P,
Primary Author: 
Sauta E
Journal Title: 
Journal of Clinical Oncology
Original Publication Date: 
May 2023

Purpose: 

Bone Marrow Disease(s): 

Epidemiology and Pathogenesis of Myelodysplastic Syndrome

Author(s): 
Rotter LK, Shimony S, Ling K, Chen E, Shallis RM, Zeidan AM, Stahl M
Primary Author: 
Rotter LK
Journal Title: 
The Cancer Journal
Original Publication Date: 
May 2023

Myelodysplastic syndrome (MDS) is a clonal disorder characterized by ineffective hematopoiesis and variable cytopenias with a considerable risk of progression to

Bone Marrow Disease(s): 

Genomics of myelodysplastic/myeloproliferative neoplasm

Author(s): 
Patwardhan PP, Aarabi M, Aggarwal N
Primary Author: 
Patwardhan PP
Journal Title: 
Seminars in Diagnostic Pathology
Original Publication Date: 
May 2023

Myelodysplastic/ Myeloproliferative neoplasms (MDS/MPN) demonstrate overlapping pathologic and molecular features of myelodysplastic (MDS) and myeloproliferative (MPN) neoplasms. Diagnosis is difficult based on morphology alone, requiring exclusion of various non-neoplastic causes for CBC abnormalities and morphologic findings and other myeloid neoplasms.

Bone Marrow Disease(s): 

The Effect of Respiratory Viral Infections on Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria

Author(s): 
Lazana I, Apap Mangion S, Babiker S, Large J, Trikha R, Zuckerman M, Gandhi S, Kulasekararaj AG
Primary Author: 
Lazana I
Journal Title: 
International Journal of Molecular Sciences
Original Publication Date: 
May 2023

Bone Marrow Disease(s): 

Current use of androgens in bone marrow failure disorders: a report from the Severe Aplastic Anemia Working Party of the European Society of Blood and Marrow Transplantation

Author(s): 
Pagliuca S, Kulasekararaj AG, Eikema DJ, Piepenbroek B, Iftikhar R, Satti TM, Griffin M, Laurino M, Kupesiz A, Bertrand Y, Fattizzo B, Yakoub-Agha I, Aljurf M, Corti P, Massaccesi E, Lioure B, Calabuig M, Klammer M, Unal E, Wu D, Chevallier P, Forcade E,
Primary Author: 
Pagliuca S
Journal Title: 
Haematologica
Original Publication Date: 
May 2023

Androgens have represented the historical therapeutic backbone of bone marrow failure (BMF) syndromes.

Bone Marrow Disease(s): 

The role of androgen therapy in acquired aplastic anemia and other bone marrow failure syndromes

Author(s): 
Nassani M, Fakih RE, Passweg J, Cesaro S, Alzahrani H, Alahmari A, Bonfim C, Iftikhar R, Albeihany A, Halkes C, Ahmed SO, Dufour C, Aljurf M
Primary Author: 
Nassani M
Journal Title: 
Frontiers in Oncology
Original Publication Date: 
May 2023

Bone marrow failure syndromes are a heterogeneous group of diseases.

Bone Marrow Disease(s): 

2023 AAMDSIF Patient and Family Conference in Dallas, TX

Join patients, families and caregivers for the 2023 Dallas, TX Patient and Family Conference This event is chaired and organized by Dr. Taha Bat from UT Southwestern.

Event Date: 
Sat, 11/04/2023 - 9:30am (EDT)
2023 Patient and Family Conference - Dallas, Texas »
Bone Marrow Disease(s): 
Conference Event Type: 
Patient and Family - Regional One Day